受访医生认为BTK抑制剂治疗复发/难治慢性淋巴细胞白血病(CLL)/小淋巴细胞淋巴瘤(SLL)相比化疗的主要优势. This evidence concerns the gene BTK and B-cell chronic lymphocytic leukemia.